ADENOSINE is a potent extracellular messenger in the heart. It causes coronary vascular smooth muscle relaxation (Schnarr and Sparks, 1972) , inhibits norepinephrine release from sympathetic nerve endings (Verhaeghe and Vanhoutte, 1977) , reduces atrioventricular node conduction velocity (Belardinelli et al., 1983) , and has negative inotropic (Dobson and Fenton, 1983 ) and chronotropic (Belardinelli et al., 1983) effects. The increase in our knowledge of the actions of adenosine has been complemented by information on the physiological conditions under which adenosine formation is increased. Hypoxia, ischemia, catecholamines, calcium, and sympathetic nerve activation are among the stimuli which cause elevated adenosine formation (Berne, 1980; Schrader, 1983) . Another area of intense activity has been the study of the biochemical pathways for adenosine metabolism. We now know that adenosine can be formed both extra-and intracellularly, and that both adenosine monophosphate (AMP) and s-adenosylhomocysteine (SAH) can serve as immediate precursors for adenosine (Schrader, 1983) . With this information it is possible to draw conclusions about the signals responsible for altering the formation of adenosine. The purpose of this review is to evaluate several hypotheses which provide explanations for adenosine formation in response to a variety of interventions. Before considering these hypotheses, we will briefly review the cellular sources and sinks for adenosine and the conditions which result in its increased formation.
Sources and Sinks of Adenosine

5'-Nucleotidase
This enzyme has been thought to be primarily responsible for the formation of adenosine (see Berne, 1980 for references). Some 5'-nucleotidase activity is associated with the plasma membrane, and its active site is available to substrates in the extracellular fluid (Frick and Lowenstein, 1976 ). This ectoenzyme is thought to be associated closely with the nucleoside carrier, because adenosine formed from infused AMP is more rapidly transported than infused adenosine itself (Frick and Lowenstein, 1978; Rovetto, 1985) . No plasma membrane carrier for transport of AMP from cytosol to extracellular fluid has been described (Rovetto, 1985) . In vitro studies indicate that membrane-associated enzyme is inhibited by cytosolic concentrations of ATP and adenosine diphosphate (ADP) (Lowenstein et al., 1983) . Lowenstein et al. (1983) and Worku and Newby (1983) have recently described a cytosolic 5'-nucleotidase in rat heart. It has a much higher K m for AMP and is stimulated, not inhibited, by ADP and ATP. This cytosolic enzyme may be responsible for the formation of intracellular adenosine from AMP. Worku and Newby (1983) have shown that, in leukocytes and hepatocytes, formation of adenosine via this enzyme may be linked to the energy charge [(ATP + 1/2 ADP) (ATP + ADP + AMP)] (Atkinson, 1968) .
There are several possible sources for the AMP which serves as a precursor for adenosine. The presence of the ecto-5'-nucleotidase suggests that extracellular adenine nucleotides, released from platelets (Fukami et al., 1976) , nerves (Burnstock, 1972) , cardiac myocytes (Forrester and Williams, 1977) , or endothelial cells (Pearson et al., 1980) , could serve as a source of AMP. The ectoenzymes necessary to degrade ATP to AMP are present (Pearson et al., 1980) .
The most obvious pool of AMP is cytosolic AMP in equilibrium with free ADP and ATP. When the phosphorylah'on potential of cells is decreased, the increased AMP favors the formation of cytosolic adenosine. A second source of intracellular AMP may be cyclic adenosine monophosphate (cAMP). The idea of separating this pool from the AMP in equilibrium with cytosolic nucleotides is supported by the experiments of Schrader and Gerlach (1976) . They pulse-labeled the adenine nucleotides of 194 guinea pig hearts and found that, under control conditions, adenosine in the effluent and cAMP in the heart had similar, relatively high, specific activities. This finding suggested that cAMP and adenosine have a precursor-product relationship with a small but highly labeled ATP pool. As we will discuss later, it is probable that most of the radioactivity came from endothelial cells, rather than myocytes, suggesting that the comparrmentation of the highly labeled ATP could be on a cellular not subcellular basis.
A third pool of AMP is that associated with mitochondria. Calculations using adenylate kinase equilibrium kinetics (McGilvery et al, 1974) suggest that most AMP cannot be in equilibrium with cytosolic ATP and ADP. Bunger et.al. (1983) have provided experimental support for these calculations. Approximately 90% of cellular AMP is associated with a mitochondrial pellet centrifuged through an organic layer, and this AMP probably is located in the mitochondrial matrix. A mitochondrial fraction isolated from rat hearts has been shown to produce adenosine (Bukoski et al., 1983) . This suggests that the AMP stores in mitochondria may be a precursor of cytosolic adenosine.
S-Adenosylhomocysteine (SAH) Hydrolase
The formation of adenosine from SAH, a product of all s-adenosylmethionine-dependent transmethylation reactions, is catalyzed by SAH hydrolase. This pathway may be a significant source of cytosolic adenosine in cardiac tissue .
Release of adenosine into venous effluent of isolated hearts is reduced during administration of lhomocysteine, which traps tissue adenosine as SAH . Although the equilibrium constant of the reaction favors formation of SAH, its hydrolysis can occur when adenosine is continuously removed. When this is the case, adenosine formation via this pathway may be related to the rate of methylation reactions involving s-adenosylmethionine (Hershfield, 1983) . The quantitative importance of this pathway, compared to 5'-nucleotidase pathways in the heart, has yet to be evaluated. Adenosine tightly binds to SAH hydrolase and cannot be acted upon by adenosine deaminase (Ueland, 1983) . A large portion of intracellular adenosine may be in this bound form. If this is so, its slow release from this binding site probably precludes it as a significant source of free cytosolic adenosine (Olsson et al., 1982) .
Adenosine Deaminase
This enzyme is present in cardiac (Arch and Newsholme, 1978) and endothelial cells (Nees and Gerlach, 1983) . The equilibrium constant strongly favors the formation of inosine. Although the K m is quite high, the relatively high V^ of the enzyme means that it can be a major sink for adenosine (Manfredi and Holmes, 1985) . At high concentraCirculation Research/Vo/. 58, No. 2, February 1986 et al. (1983) . § Worku and Newby (1983) . | Ueland (1983) . 1 Arch and Newsholme (1978) .
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tions of cytosolic adenosine, it is probably the major pathway for degradation (see below).
Adenosine Kinase
This enzyme has a lower K m than adenosine deaminase, but its relatively low V^ means that it may be quite close to saturation under resting conditions (see Schrader, 1983) . Because of this, increased cytosolic adenosine may not result in a proportionate increase in formation of AMP from adenosine. In some cases, i.e., when exogenous adenosine is presented to cells (Manfredi and Holmes, 1985) , deamination is a quantitatively more significant sink than is phosphorylation. Newsholme (1978a, 1978b) have proposed that adenosine kinase and 5'-nucleotidase are joined in a substrate cycle which magnifies the effect of increased hydrolysis of AMP on adenosine concentration. This proposal would be applicable to cells in which adenosine kinase activity is close to its V max under control conditions. Newby et al. (1983) have evaluated the role of this proposed cycle in polymorphonuclear leukocytes, cultured neonatal rat heart cells and isolated perfused rat hearts. They found that, under the conditions of their experiments, adenosine kinase is not saturated and that its inhibition did not raise tissue adenosine or effluent adenosine. These findings argue against the substrate cycle hypothesis. Schrader (1983) has proposed that there are two substrate cycles which amplify the effects of changes in adenosine formation on adenosine concentration. The second proposed cycle is via SAH hydrolase.
Cell Membrane Transport of Adenosine
Our knowledge of the nucleoside carrier of adult cardiac myocytes is extremely limited. If the transport process is like that of more thoroughly studied cells, it is nonconcentrative, directionally symmetrical, and has roughly equal affinity for adenosine and inosine (Plagemann and Wohlhueter, 1983) . The steady state uptake of adenosine is probably limited by its cytosolic concentration, not saturation of the carrier. Because of the large capacity for membrane transport, release of adenosine from cells is probably the result of a small concentration gradient between cytosol and extracellular fluid.
Capillary Transport of Adenosine
Although adenosine undoubtedly moves between the interstitial fluid (1SF) and plasma by simple diffusion, capillary endothelial cells can act as a source of sink for plasma adenosine (Sparks et al., 1985) . Recent studies have demonstrated that coronary endothelial cells in culture (Nees and Gerlach, 1983) are capable of releasing adenosine. Furthermore, it is possible to label selectively the nucleoride pool of in situ endothelial cells of isolated perfused guinea pig hearts (Nees and Gerlach, 1983) . Experiments using this technique suggest that a large fraction of adenosine appearing in the venous effluent of unstimulated hearts comes from endothelial cells (Bardenheuer et al., in press ). However, these same studies show that when adenosine release is elevated by a variety of stimuli, it comes from myocytes, not endothelial cells. Endothelial cells also take up adenosine, incorporate it into their nucleoride pool (Pearson et al., 1978; Nees and Gerlach, 1983) , and deaminate it (Ryan and Smith, 1971) . Experiments employing the single pass extraction technique demonstrate that approximately 3 times as much plasma adenosine is taken up by the luminal surface of endothelial cells as by paracellular diffusion (Sparks et al., 1985) . This means that at physiological levels, 75-90% of infused adenosine (depending on the extent of abluminal endothelial cell uptake) would not reach vascular smooth muscle, nerves, and myocardium. The measurements and calculations of Nees and Gerlach (1983) suggest that the higher estimate (90%) of adenosine uptake by endothelial cells is the correct one. Doseresponse curves obtained by intraarterial infusion of adenosine must be reevaluated in light of this. Assuming that adenosine acting directly on vascular smooth muscle is responsible for the observed vasodilation (De Mey et al., 1982; Gordon and Martin, 1983) , adenosine may be 10-fold more potent than previously estimated from such dose-response curves. Furthermore, venous effluent adenosine concentration cannot be used to quantitatively estimate interstitial fluid adenosine concentration without taking into account endothelial cell uptake and release .
Factors Influencing Adenosine Formation
Indices of Adenosine Formation
There are three widely used indices of adenosine formation by the heart. They are (1) tissue adenosine content, (2) pericardial suffusate adenosine concentration, and (3) venous effluent concentration or release. Tissue adenosine content represents the sum of intracellular and interstitial adenosine. A large fraction of tissue adenosine is bound to SAH hydrolase (Olsson et al., 1982) . For this reason, it is impossible to calculate the concentration of free adenosine in cellular or interstitial water from tissue content measurements. However, it is probably safe to use changes in tissue adenosine content as a reflection of changes in net formation of adenosine because: (1) intra-and extracellular free adenosine concentrations are likely to be about equal (see earlier discussion of adenosine transport), (2) increased net formation of adenosine should cause an increase in both intra-and extracellular free adenosine, (3) the relatively slow association and dissociation of adenosine from its SAH hydrolase-binding site will distort the proportionality of changes in formation to tissue content, but not the directional concordance.
Pericardial suffusate adenosine concentration reflects the balance between the net rate of diffusion from the surface of the myocardium and loss to the pericardium. There is controversy about the meaning of timed collections of pericardial suffusate when there has been insufficient time for a steady state to be reached (Kusachi and Olsson, 1983; Berne et al., 1983) . Despite this, we have assumed that an increase in pericardial fluid adenosine reflects an increase in net formation of adenosine, even though its cellular and subcellular source is unknown. A modification of this technique, involving an epicardial well, has been introduced by Hanley et al. (1983) . Although there is no direct proof concerning the origin of adenosine appearing in the well, it is likely to be a better index of net formation of adenosine because the well eliminates the possibility of loss to the pericardium.
Finally, venous plasma adenosine concentration is influenced by interstitial fluid adenosine concentration, as well as by arterial plasma adenosine, plasma flow, and endothelial and blood cell uptake and release . Again, despite the variety of factors which can affect venous adenosine, we will assume that an increase in venous plasma adenosine concentration or release (the difference between venous and arterial concentration times flow) reflects increased adenosine formation. Our mathematical model of capillary transport of 196 adenosine indicates that venous concentration is a better index of interstitial concentration than is net release, because perfusion rate influences reuptake of adenosine by capillary endothelial cells. That is, increased flow reduces uptake of plasma adenosine and raises the amount appearing in venous effluent . The available data indicate that the source of adenosine released in response to several stimuli is cardiac myocytes, not endothelial cells (Bardenheuer et al., in press; Schrader and Gerlach, 1976) . It should be noted that each of the three indices reflects overall changes in net adenosine formation; local changes may be considerably different.
Decreased Oxygen Supply
Hypoxia and hypoperfusion cause degradation of adenine nucleotides and increased release of adenosine, inosine, and hypoxanthine into venous effluent. Hypoxia and hypoperfusion also elevate tissue nucleoside content and increase pericardial fluid adenosine concentration (see Berne and Rubio, 1979) . However, because of the higher washout of metabolites in the case of hypoxia, the two interventions differ in their influence on cardiac metabolism. For example, Downey et al. (1982) found that tissue adenosine is much lower during hypoxia than during ischemia.
Several lines of evidence substantiate the view that adenosine released during hypoxia is formed inside heart cells. First, inhibition of ecto-5'-nucleotidase by a,/J-methylene adenosine 5'-diphosphate (AOPCP) does not reduce adenosine release into the venous effluent during hypoxia . This indicates that ecto-5'-nucleotidase is not necessary for the formation of adenosine in this situation. Second, 4-nitrobenzylthioinosine (NBMPR) an inhibitor of nucleoside transport, raises tissue content of adenosine but reduces its release into venous effluent in the presence of hypoxia . Finally, administration of /-homocysteine thiolactone during hypoxia inhibits release of adenosine and causes the buildup of SAH . The latter two points can be interpreted to indicate that adenosine is formed in the cytosol and is transported to the extracellular fluid by the nucleoside carrier. Newby and Holmquist (1981) reached the same conclusion for adenosine formation in response to nucleotide degradation in leukocytes. On the other hand, we have recently found that both NBMPR and AOPCP inhibit adenosine release from myocytes isolated from rat hearts and treated with dinitrophenol. This suggests that, in this preparation, some adenosine is formed via ecto-5'-nucleotidase. Schrader and Gerlach (1976) provided evidence on the source of the adenosine released during ischemia. They pulse labeled the adenine nucleotide pool of isolated guinea pig hearts by infusing [ 14 C]-adenine. After a brief period for washout of intravascular tracer, they found that-under control conCirculation Research/Vo/. 58, No. 2, February 1986 ditions-the specific activity of adenosine in the venous effluent was much higher than that of tissue nucleotides, but similar to that of cAMP. This suggests that, under control conditions, effluent adenosine comes from a small highly labeled pool, perhaps related to cAMP metabolism. With ischemia, the specific activity of effluent adenosine dropped toward the tissue nucleotide values, suggesting that a larger less well labeled pool made an increased contribution to effluent adenosine. This could represent the contribution of adenosine resulting from cardiac myocyte adenine nucleotide degradation. At the time these experiments were done, the ability of coronary endothelial cells to take up adenosine was not recognized (Pearson et al., 1978; Nees and Gerlach, 1983; Sparks et al., 1985) . It is probable that endothelial cell nucleotides were selectively labeled in these experiments. This new information does not change the basic conclusion that myocyte adenine nucleotide degradation is responsible for most of the adenosine released during ischemia.
Hypoperfusion of isolated guinea pig hearts results in a prompt increase in the release of adenosine into venous effluent. During steady state conditions, release falls to approximately half the peak value and is sustained at that level for up to 3 hours (Wangler et al., 1984) . The reduction in adenosine release is not accompanied by changes in coronary flow or myocardial O 2 consumption. The early peak, but not the sustained release, is blocked by d\-propranolol (10~7 M), suggesting that catecholamines are involved in the initial but not the maintained response to ischemia. A higher concentration of dlpropranolol (10~5 M) or d-propranolol (which has membrane stabilizing, but not 0-adrenergic receptor antagonist properties) totally eliminates the adenosine release resulting from hypoperfusion. This could represent an effect on adenine nucleotide degradation or the membrane transport of adenosine out of the cytosol.
Increased Myocardial Oxygen Consumption
The increase in myocardial O 2 consumption (MVO2) in response to catecholamine administration is associated with increased tissue (Saito et al., 1980) , venous (Manfredi and Sparks, 1982) , and pericardial adenosine (Berne and Rubio, 1979) . In general, there is a positive correlation between the increase in MVO 2 and the increase in adenosine (Berne et al., 1983) . The increase in venous adenosine release caused by isoproterenol is primarily from cardiocytes, not endothelial cells (Bardenheuer et al., in press ). When norepinephrine is infused into isolated nonworking guinea pig hearts, coronary flow, MVO 2 and adenosine release into venous effluent reach maximum within 1 minute. Although the coronary flow and MVO 2 remain steady after this time, adenosine release immediately begins to fall, reaching steady state (5 times control, but 1/8 maximum) after 9 minutes. A qualitatively similar result is obtained in the presence of the ai-adrenergic antag- The close relationship between MVO 2 and adenosine release in some studies suggests that nucleoside release is proportional to ATP turnover. In recent years, however, experimental conditions have been described in which adenosine release did not parallel the increase in MVO2. Wiedmeier and Spell (1977) reported that several inotropic stimuli, but not cardiac pacing, increase adenosine release from isolated guinea pig hearts. Manfredi and Sparks (1982) compared the effect of cardiac pacing and norepinephrine infusion on adenosine release into coronary venous blood of dogs. Although MVO 2 was raised equally by the two stimuli, adenosine release after 10 minutes was elevated in the presence of catecholamine, but not pacing. Also, Saito et al. (1980) found that tissue adenosine content of dog hearts increased in response to several stimuli, but not cardiac pacing. On the other hand, Berne et al. (1983) found that cardiac pacing of anesthetized and unanesthetized dogs increased adenosine release into venous blood and adenosine content of pericardial fluid. They reported that the increase in adenosine, for a given increase in MVO 2 , is very similar to the results obtained with catecholamines. This conflict might be explained by our recent finding that adenosine release from rat hearts is initially increased when heart rate is elevated by cardiac pacing, but rapidly returns to control in the presence of continued pacing (Heller et al., 1984) . This suggests that discrepancies among different studies may be the result of timing of sampling. Furthermore, pericardial adenosine (an integrated measure of adenosine formation) would not be as sensitive to the timing of adenosine formation as venous effluent adenosine (a virtually instantaneous measure of formation).
Tissue adenosine content of in situ dog (McKenzie et al., 1980) and rat (Foley et al., 1978) hearts is increased after aortic constriction. More recently, Bardenheuer and Schrader (1983) found that the adenosine release from isolated working guinea pig heart does not increase when afterload is raised. This is true even though other stimuli, which raise MVO 2 an equivalent amount, stimulate adenosine release. The conflict with earlier results may be explained if aortic constriction induces release of both acetylcholine and norepinephrine. It is possible that the increase in adenosine formation observed in the studies on in situ hearts is mediated by a secondary release of endogenous catecholamines and/or acetylcholine. However, another study by Knabb et al. (1983) was performed in the presence of /9-blockade, and so this may not be the full explanation. We think that most of the evidence indicates that, during steady state conditions and for a given increase in MVO2, cardiac pacing and increased afterload do not increase adenosine formation as much as norepinephrine or isoproterenol.
However, there is still genuine controversy in this area, and more studies are needed.
There are a number of other stimuli which cause adenosine release. Ultimately, any explanation of the regulation of adenosine formation must be consistent with these observations, in addition to those described above. Acidosis reduces MVO 2 and adenosine release from isolated guinea pig hearts. On the other hand, carbon dioxide in the absence of reduced pH also reduces MVO 2 , but increases adenosine release (Bardenheuer and Sparks, 1984) . Acetylcholine, which reduces myocardial contractile performance, stimulates adenosine release (Schrader et al., 1982) . Amytal reduces oxidarive phosphorylation and increases adenosine release from isolated hearts (Nuurinen et al., 1982) . Acetate raises cytosolic AMP and results in increased myocardial adenosine in dogs (Liang, 1978) .
Physiological Signals for Adenosine Formation
The studies cited above make it clear that adenosine can be formed from two precursors via at least three enzymatic pathways, and that the rate of formation can be changed by a variety of stimuli. In the case of methylation reactions, adenosine is only a by-product. On the other hand, the regulation of the 5'-nucleotidases would seem to be specifically related to the control of adenosine formation. In the next section we will be concerned with identifying the physiological signals responsible for net adenosine formation. The above account leads us to consider the role of three physiological determinants of the formation of adenosine: (1) oxygen supply:demand ratio, (2) myocardial O 2 consumption, and (3) extracellular nucleotide release.
Oxygen Supply.Demand
In his earliest statements of the adenosine hypothesis for regulation of coronary blood flow, Berne suggested that the ratio of oxygen consumption to oxygen supply was part of a negative feedback loop regulating adenosine release (Berne et al., 1964) . This idea has been reintroduced by Bardenheuer and Schrader (1983) . In this scheme, adenosine formation is imbedded in the feedback loop as the effector responsible for determining coronary vascular conductance. This is the substrate form of the hypothesis as described by Feigl (1983) . That is, formation of adenosine is related to the availability of oxygen relative to the demand for its use.
Before discussing the merits of the supply:demand hypothesis in detail, we will define components of this ratio. Oxygen supply is the average rate at which O 2 is presented to the mitochondria of cardiac myocytes. The denominator of the ratio, O 2 demand, is defined as the potential for O 2 consumption, given adequate O 2 supply. For example, norepinephrine causes increased force of contraction and increased ATP use. If it were infused in the presence of a flow-limiting coronary artery stenosis, ATP synthesis (and O 2 consumption) would be limited by in-198 adequate O 2 supply. In this situation, if more O 2 were supplied, more would be used. It is this potential to consume O2 (and synthesize ATP) which we define as O 2 demand. In general, a fall is tissue P02 would be a sign that O 2 supply/demand has decreased, and we will take a decrease in venous P02 as an index of a fall in tissue Po 2 .
Oxygen supply:demand must be linked to a chemical signal capable of regulating synthesis of adenosine. We think that Nuutinen et al. (1982) have come closest to describing such a link. They have shown that coronary blood flow of an isolated perfused rat heart is inversely proportional to the cytoplasmic phosphorylation potential:
where the subscript f refers to the free cytosolic concentration of ATP and ADP. Although we do not necessarily agree with their rejection of adenosine as the mediator of changes in blood flow, that subject is beyond the scope of this review. Our reading of their data is that a fall in the phosphorylation potential is associated with an increase in adenosine release.
It is possible that the cytoplasmic phosphorylation potential or another closely related variable is responsible for regulating adenosine formation. Worku and Newby (1983) suggest that energy charge (Atkinson, 1968 ) is a cellular signal which controls adenosine formation. They showed that adenosine formation in rat polymorphonuclear leukocytes, during 2-deoxyglucose-induced nucleotide catabolism, was highest at an energy charge of ~0.8. A cell-free system showed a similar dependence of adenosine formation in energy change. Furthermore, in 1974, Rubio et al. found that the fall in energy charge of isolated perfused guinea pig hearts predicted the rise in adenosine release. Worku and Newby argue that cytosolic 5-nucleotidase is the enzyme most likely to be regulated by the energy charge. Such a mechanism would explain an interesting coincidence. When the isolated rodent heart is stimulated, both glycolysis (Neely and Morgan, 1974) and adenosine release (DeWitt et al., 1983 ) exhibit an early peak and then fall to a steady state level which is greater than control. This could be because they are both influenced by signals related to the phosphorylation potential.
The O 2 supply:demand hypothesis fulfills the criterion that a reduction in O 2 delivery to the heart should cause increased adenosine formation. Reduced delivery would result in inadequate supply of O2 to mitochondria and reduced ATP synthesis in the presence of a steady ATP use. This would increase the signal driving oxidaidve phosphorylation, e.g., ADP availability (Jacobus, 1985) , and also adenosine formation.
The hypothesis also predicts an increase in adenosine formation when there is an increase in O 2 consumption relative to O 2 supply. As indicated above, this hypothesis can explain the initial overshoot in adenosine release after administration of Circulation Research/Vol. 58, No. 2, February 1986 catecholamines to the isolated perfused guinea pig heart. When cardiac performance and ATP use is first increased, ATP synthesis may not be sufficiently elevated because the cellular signal for increased oxidative phosphorylation is not high enough. The fall in phosphorylation potential (or rise in AMP) would cause a high rate of adenosine formation. As coronary flow, O 2 delivery, and oxidative phosphorylation increase, oxygen supply:demand would increase and phosphorylation potential would fall, as would the formation of adenosine.
If this hypothesis is correct, increased adenosine formation associated with increased ATP use should not be elevated in any case where the O 2 supply:demand ratio is at the control value. For example, if delivery of O 2 is raised to a greater extent than occurs during increased metabolism, adenosine release should be minimized because no reduction in supply:demand ratio would have occurred. In control theory terms, the negative feedback loop would have been opened. Bardenheuer and Schrader (1983) examined adenosine release in response to elevated afterload of the isolated working guinea pig heart. Because elevation of afterload simultaneously increases coronary perfusion pressure, flow, and myocardial O 2 consumption, the ratio of O 2 supply to consumption was actually increased. If the supply:demand hypothesis is correct, no increase in adenosine formation should occur. This was the observed result.
However, a companion experiment suggests supply:demand ratio is not the only determinant of the adenosine release. If adenosine formation were solely responsive to supply:demand ratio, formation would decrease as the ratio increased. When flow was held constant at a high level and afterload was varied, no change in adenosine release occurred. These experiments suggest that the basal release of adenosine may not be regulated by O 2 supply:demand. In other experiments, the effect of agents which stimulate ATP use and also directly cause coronary vasodilation were compared to norepinephrine, an agent which stimulates ATP use, but is a direct coronary vasoconstrictor (Mohrman and Feigl, 1978) . At the same myocardial O 2 consumption, adenosine release was higher in the presence of norepinephrine than with those substances with direct vasodilator effects. This is the result predicted from the O 2 supply:demand hypothesis.
A similar explanation can be given for the rise in adenosine formation, when myocardial metabolism is stimulated by isoproterenol. Although the /9-adrenergic agent has a direct vasodilatory influence on coronary resistance vessels, venous Po 2 falls in the isolated perfused guinea pig heart. This indicates a decrease in O 2 supply:demand. Judging from the rapid onset of the changes on contractile force, MVO 2 increases before O 2 supply, and so the initial ratio is much lower than the steady state ratio. This results in an initial peak in the adenosine release, followed by a lower release during steady state by guest on July 9, 2017 http://circres.ahajournals.org/ stimulation (DeVVitt et al., 1983) .
Another experimental result which can be explained by this ratio is the lack of steady state increase in adenosine accompanying increases in heart rate in some experiments on in situ dog hearts (Manfredi and Sparks, 1982) and isolated guinea pig hearts (Wiedmeier and Spell, 1977) . Increased heart rate causes a transient increase in adenosine release in isolated perfused rat hearts, but no steady state increase (Heller et al., 1984) . We propose that with the initiation of cardiac pacing, O2 demand outstrips O 2 supply and adenosine release increases. Then, as flow increases, a point is reached where the balance of O 2 demand and O 2 supply is established and adenosine release falls to the control level.
The hypothesis is more severely tested by experiments on blood-perfused dog hearts, in which infusion of isoproterenol does not result in a fall of coronary sinus Po 2 (Manfredi and Sparks, 1982) . In this situation, as with cardiac pacing and increased afterload, no increase in adenosine formation would be predicted. Yet, adenosine formation is increased. If we assume that these measurements are taken during a steady state and that isoproterenol does not influence the uptake of nucleosides, the results rule out O 2 supply:demand as the sole factor determining the formation and release of adenosine.
Myocardial O 2 Consumption
As indicated above, there are instances in which a decreased O 2 supply:demand does not appear to be the signal for increased adenosine formation. An alternative or supplemental signal could be related to increased myocardial O 2 consumption, regardless of O2 supply or demand. Berne (1980) has proposed that increased ATP use is accompanied by shifts in the nucleotide pool which increase the activity of 5'-nucleotidase via magnesium and creatine phosphate. Although this hypothesis includes a specific role for ecto-5'-nucleotidase, it could be altered to include a 5'-nucleotidase with cytosolic activity. The MVO 2 hypothesis, as described here, predicts that formation of adenosine is linked to MVO 2 , regardless of the stimulus or flow conditions. This is the metabolite form of the hypothesis as described by Feigl (1983) , because adenosine formation is related to metabolic rate. It is interesting to examine the MVO2 hypothesis from the standpoint of control theory. If, as proposed, adenosine formation is directly related to MVO 2 , then it is not a part of a negative feedback loop involving delivery of O 2 to cardiac cells. Instead, adenosine formation would proceed independent of O2 supply.
There are a number of studies in which a positive correlation between MVO2 and pericardial adenosine concentration is stressed (see Berne et al., 1983) . The correlation coefficients are relatively modest, suggesting that the variation in MVO 2 is responsible for approximately half of the variance in pericardial adenosine. One reason for the relatively low correlation coefficient could be that the relationship between MVO2 and the formation of adenosine varies depending on the stimulus. Studies from several laboratories support this possibility. We have already described studies in which cardiac pacing (Weidmeier and Spell, 1977; Saito et al., 1980; Manfredi and Sparks, 1982) and increased afterload (Bardenheuer and Shrader, 1983) did not result in increased steady state adenosine formation, even though MVO 2 was markedly enhanced. Furthermore, when catecholamines or calcium are infused, the release of adenosine is phasic in the face of a steady increase in MVO 2 (DeWitt et al., 1983) . This also could contribute to a relatively poor correlation between MVO 2 and any index of adenosine formation.
The above data suggest that the correlation between adenosine formation and increased MVO 2 is not good enough to support the hypothesis that a common cellular signal relates these two variables. A possible explanation for the partial correlation between MVO 2 and indices of formation of adenosine is that other factors, which have a variable relationship to MVO 2 , are responsible for adenosine formation. The two most probable factors are the O2 supply:demand ratio previously described and extracellular nucleotide release discussed next.
Adenosine Formation from Extracellular Nucleotides
The O2 supply:demand hypothesis predicts increased adenosine release during ischemia, hypoxia, norepinephrine infusion, and sympathetic nerve stimulation. It does not predict an increased nucleoside release during steady state infusion of isoproterenol, when the supply:demand ratio of oxygen can be assumed to be balanced as indicated by an unchanged Po 2 in coronary sinus blood. Under these conditions, there must be at least one other signal for the release of adenosine. One possible explanation may be a catecholamine-induced nucleotide release. Fredholm et al. (1982) have demonstrated that during sympathetic nerve stimulation, ATP is released by the isolated heart. However, AOPCP, which blocks 5'-nucleotidase, only slightly reduces the release of adenosine, suggesting that extracellular nucleotides contribute only a little to the total release of adenosine during nerve stimulation. This would be expected because this stimulus lowers O 2 supply:demand (Mohrman and Feigl, 1978) , which could account for most of the observed adenosine release. Unfortunately, the influence of AOPCP on isoproterenol-induced adenosine release has not been reported.
The source of extracellular adenine nucleotides remains to be elucidated. Olsson et al. (1973) proposed that AMP formed by the action of phosphodiesterase on cAMP could be responsible for adenosine formation. Schrader and Gerlach's (1976) specific activity data support this hypothesis for basal release, but not hypoxia. Kohn and Garfinkle (1977) have developed a computer model of rat heart purine metabolism which predicts that adenosine release during ischemia is the result of local norepinephrine release which causes increased cAMP and,
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Circulation Research/Vo/. 58, No. 2, February 1986 therefore, increased adenosine formation. This idea is consistent with studies which show that catecholamines cause the release of cAMP from isolated rodents hearts (O'Brien and Strange, 1975; Imai et al., 1978) . The 0-adrenergic receptor blocker, dlpropranolol reduces the early release of adenosine during ischemia, which is consistent with the above model (Wangler et al., 1984) .
Other stimuli cause the release of adenine nucleotides from the heart. Acetylcholine causes increased release of ATP and AMP, as well as adenosine (Schrader et al., 1982) . Nucleotide release could explain the paradoxical increase in adenosine release caused by this agent, which results in increased O 2 supply:demand. Hypoxia also causes release of ATP from the heart (Paddle and Burnstock, 1974 ). In the above situations, the source of the ATP is also unknown. Possibilities include cardiac myocytes (Forrester and Williams, 1977) , sympathetic or purinergic nerves (Burnstock, 1983) , and endothelial cells (Pearson and Gordon, 1985) . Regardless of the source, the presence of extracellular degradative enzymes (Pearson et al., 1980) assures that little of it will escape into venous effluent as ATP.
Summary
We think that the available data on adenosine formation suggest the two signals are responsible for adenosine release from cardiac myocytes: (1) the ratio of oxygen supply to demand and (2) agonisttriggered release of extracellular adenine nucleotides. We do not believe that the available data support the oxygen consumption hypothesis. The few studies which allow us to judge the relative importance of these two signals suggest that both hypoxia and sympathetic nerve stimulation release adenosine primarily by decreasing O 2 supply:demand. Agonist triggered nucleotide release may be quantitatively important in situations in which decreased O 2 supply/demand cannot explain increased release, i.e., isoproterenol and acetylcholine administration.
